Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Eczmol 1% w/w Cream / Cetraben Protect Antimicrobial 1% Cream

Active Ingredient:
chlorhexidine gluconate solution
Genus Pharmaceuticals See contact details
ATC code: 
About Medicine
{healthcare_pro_orange} This information is for use by healthcare professionals
Last updated on emc: 05 Oct 2023
1. Name of the medicinal product

Eczmol 1% w/w Cream

Cetraben Protect Antimicrobial 1% Cream

2. Qualitative and quantitative composition

Chlorhexidine Gluconate 1% w/w.

(incorporated as Chlorhexidine Gluconate Solution 5.0 % v/w)

Excipient(s) with known effect

Cetostearyl alcohol 2% w/w

For full list of excipients, see section 6.1

3. Pharmaceutical form


A white, smooth, pourable cream

4. Clinical particulars
4.1 Therapeutic indications

Eczmol/Cetraben Protect Cream is an antimicrobial emollient which can also be used as an alternative to soap in the management of dry and pruritic skin conditions including eczema and dermatitis.

4.2 Posology and method of administration

For cutaneous use. For external use only.

For adults, the elderly, infants and children

For application to the skin

Apply to the affected areas as often as necessary.

For use as a soap substitute

Eczmol/Cetraben Protect Cream may also be used as a cleanser in the bath or shower, or for other toiletry purposes, instead of ordinary soap or shower gel.

4.3 Contraindications

Known hypersensitivity to the product or any of its components, especially in those with a history of possible Chlorhexidine-related allergic reactions (see section 4.4 and 4.8)

4.4 Special warnings and precautions for use

Eczmol/Cetraben Protect Cream contains chlorhexidine. Chlorhexidine is known to induce hypersensitivity, including generalised allergic reactions and anaphylactic shock. The prevalence of chlorhexidine hypersensitivity is not known, but available literature suggests this is likely to be very rare.

Eczmol/Cetraben Protect Cream should not be administered to anyone with a potential history of an allergic reaction to a chlorhexidine-containing compound (see sections 4.3 and 4.8).

For topical application only. Keep out of the eyes and ears and avoid contact with the brain and meninges.

Hypersensitivity to some of the ingredients of Eczmol/Cetraben Protect Cream may be more common in patients with leg ulcer or stasis dermatitis. This medicine should therefore be used in caution in these patients.

Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.

This product can make skin and surfaces slippery after use. As a result, patients should be advised to take care following use, especially when entering or leaving the bath/shower.

Ingredients with specified warnings

This medicine contains cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis).

4.5 Interaction with other medicinal products and other forms of interaction

Hypochlorite bleaches may cause brown stains to develop in fabrics which have previously been in contact with preparations containing chlorhexidine.

4.6 Fertility, pregnancy and lactation

There is no evidence of any adverse effects on the foetus arising from the use of chlorhexidine during pregnancy and lactation. Therefore no special precautions are recommended.

4.7 Effects on ability to drive and use machines

None have been reported or are known.

4.8 Undesirable effects

Skin disorders

Frequency not known: Allergic skin reactions such as dermatitis, pruritus, erythema, eczema, rash, urticaria, skin irritation, and blisters.

Immune disorders

Frequency not known: Hypersensitivity including anaphylactic shock (see sections 4.3 and 4.4).

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: or search for 'MHRA Yellow Card' in the Google Play or Apple App Store.

4.9 Overdose

Accidental Ingestion

Chlorhexidine taken orally is poorly absorbed. Since there is very little absorption of chlorhexidine in the digestive tract, accidental ingestion is very unlikely to cause systemic effects. Symptoms of an overdose resemble those of alcohol intoxication (drunkenness). Nausea, vomiting, slurred speech, a staggering walk, and drowsiness may develop. In the case of massive ingestion gastro-intestinal irritation may be observed, and also hepatotoxicity. Give a glass of milk or water and employ supportive measures as appropriate.

5. Pharmacological properties
5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Biguanides and amidines, ATC Code: D08A C02

Chlorhexidine is effective against a wide range of Gram negative and Gram positive vegetative bacteria, yeasts, dermatophyte fungi and lipophilic viruses. It is inactive against bacterial spores except at elevated temperatures.

5.2 Pharmacokinetic properties

Because of its cationic nature, chlorhexidine binds strongly to skin mucosa and other tissues and is thus very poorly absorbed. There are, as a consequence, no general pharmacological studies on chlorhexidine available and its effects on internal organs are minimal. No detectable blood levels have been found in man following oral use and percutaneous absorption, if it occurs at all, is insignificant.

5.3 Preclinical safety data

Chlorhexidine is a drug on which extensive clinical experience has been obtained. All relevant information for the prescriber is provided elsewhere in the Summary of Product Characteristics.

6. Pharmaceutical particulars
6.1 List of excipients

Cetostearyl Alcohol

Macrogol Cetostearyl Ether

Isopropyl Alcohol

Liquid Paraffin

White Soft Paraffin

Purified Water

6.2 Incompatibilities

Chlorhexidine is incompatible with soap and other anionic agents.

6.3 Shelf life

3 years.

6.4 Special precautions for storage

Store below 30° C.

6.5 Nature and contents of container

250ml PP Bottle with PP/HDPE pump dispenser and tamper-evident collar

250ml HDPE shower bottle with a polypropylene cap

250ml HDPE soap dispenser pump pack

200ml polypropylene pump pack

50ml polypropylene pump pack

50ml HDPE sample pack with a polypropylene cap

6.6 Special precautions for disposal and other handling


7. Marketing authorisation holder

Genus Pharmaceuticals Limited




8. Marketing authorisation number(s)

PL 06831/0242

9. Date of first authorisation/renewal of the authorisation


10. Date of revision of the text


Genus Pharmaceuticals
Company image
Linthwaite, Huddersfield, West Yorkshire, HD7 5QH, UK
+44 (0)1484842217
+44 (0)1484847301
Medical Information Direct Line
+44 (0)1484 848164
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1484 848200
Medical Information Fax
Out of Hours Telephone
+44 (0)1484 848164